Patent · US Active

Imidazo[1,2-a]pyrazines as orexin receptor antagonists

US8129384B2 · kind B2 · utility

7Cited by
0References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 9, 2009
Grant dateMar 6, 2012
Priority date—
Expiry dateOct 9, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention relates to imidazopyrazine substituted piperidine derivatives and their use as pharmaceuticals.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.